What BIOTECH FIRM, struggling with lower than expected sales of its mRNA Covid-19 vaccine, was given nearly $600 million by the US Department of Health and Human Services to speed development of a bird flu vaccine? It had previously received $176 million towards a "pandemic influenza vaccine" that targets a number of viruses, including bird flu.
Moderna